Durham, NC, United States of America

Roman Davis

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roman Davis. Retrieved from https://idiyas.com/inventor/roman-davis-8jndmwzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Roman Davis

Introduction

Roman Davis is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on finasteride. His innovative approach has led to the development of a unique method for preparing this important compound.

Latest Patents

Roman Davis holds a patent for a "Method for preparing finasteride." This invention relates to a process that involves the reaction of a specific compound with t-butylamine, resulting in the preparation of finasteride, a compound known for its applications in treating hair loss and prostate conditions. He has 1 patent to his name, showcasing his expertise in this area.

Career Highlights

Davis is currently employed at Glaxo Wellcome Inc., a leading pharmaceutical company known for its research and development in various therapeutic areas. His role at the company allows him to contribute to groundbreaking advancements in medicine and healthcare.

Collaborations

One of his notable collaborators is Alan Millar, with whom he has worked closely on various projects. Their partnership has fostered innovation and has been instrumental in the development of new pharmaceutical processes.

Conclusion

Roman Davis exemplifies the spirit of innovation in the pharmaceutical industry. His work on finasteride and his collaboration with esteemed colleagues highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…